Sustained release systems of ascorbic acid phosphate

Details Sustained release systems of ascorbic acid phosphate Sustained release systems of ascorbic acid phosphate

2008-12-11

2011-10-11

Wax, Robert A (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C514S772400, C424S520000, C424S093210, C424S400000

Reexamination Certificate

active

08034363

ABSTRACT:
A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

REFERENCES:
patent: 5140043 (1992-08-01), Darr et al.
patent: 5578471 (1996-11-01), Fujio et al.
patent: 6046160 (2000-04-01), Obi Tabot
patent: 6491948 (2002-12-01), Buchholz
patent: 7666410 (2010-02-01), Lye et al.
patent: 2002/0019372 (2002-02-01), Schnellmann et al.
patent: 2004/0001878 (2004-01-01), DeBusk et al.
patent: 2004/0193274 (2004-09-01), Trieu
patent: 2006/0246121 (2006-11-01), Ma et al.
patent: 2008/0058410 (2008-03-01), Kim et al.
patent: 2008/0274185 (2008-11-01), Mao
patent: 2010/0150981 (2010-06-01), Li et al.
patent: 2010/0272782 (2010-10-01), Owens et al.
patent: 99/40990 (1999-08-01), None
patent: WO 0124842 (2001-04-01), None
patent: WO0215860 (2002-02-01), None
patent: WO 02100462 (2002-12-01), None
patent: WO 2004101764 (2004-11-01), None
patent: WO 2006032092 (2006-03-01), None
patent: WO 2006047310 (2006-05-01), None
patent: 2006/066227 (2006-06-01), None
patent: WO 2006133506 (2006-12-01), None
patent: WO 2007089864 (2007-08-01), None
patent: WO 2007089878 (2007-08-01), None
patent: WO2008155512 (2008-12-01), None
patent: WO2010111108 (2010-09-01), None
patent: WO2010128281 (2010-11-01), None
patent: WO2010128281 (2011-03-01), None
Long C. I. et al (2003): Ascorbic acid dynamics in the seriously ill and injured, Journal of Surgical Research, 109, 144-148.
Kim H. et al (2003): Sustained release of ascorbic-2-phosphate and deamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells, Biomaterials 24:4671-4679.
Shukla, S. P. Plasma and urinary ascorbic acid levels in the postoperative period.Experientia25: 704, 1969.
Mason, M., Matyk, P. M., and Doolan, S. A. Urinary ascorbic acid excretion in postoperative patients.Am. J. Surg. 122: 808, 1971.
Junge A. et al (2006): Modification of collagen formulation using supplemented mesh materials, Hernia, 10:492-497.
Levenson et al- Vitamins in Acute Illness Annals of Surgery 24 (5) p. 840-856 1946.

Affiliated with

Also associated with

Rating

Sustained release systems of ascorbic acid phosphate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release systems of ascorbic acid phosphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release systems of ascorbic acid phosphate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4263957